Загрузка...
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals have changed, and the prognosis has improved over two decades. We reviewed the case of a fema...
Сохранить в:
| Опубликовано в: : | Clin Hypertens |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771102/ https://ncbi.nlm.nih.gov/pubmed/31583114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40885-019-0127-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|